Headquartered in Cork, with operations across the UK and mainland Europe, the Dornan Group is currently seeking experienced professionals to join its ambitious team as it eyes up opportunities in the rapidly growing pharmaceutical sector. With long-standing expertise in this sector, Dornan is placing a renewed focus on its European pharmaceutical operations wing, further strengthening its capabilities to provide innovative solutions to existing and future clients.
The company provides integrated end-to-end solutions for mechanical, electrical, instrumentation and fit-out services to the construction industry, including biotechnology, pharmaceutical, semi-conductor, data centre, commercial and manufacturing clients, plans to fill the positions across multiple locations in Europe.
New senior roles
The new senior roles will be across a range of specialities, encompassing engineering, construction, and commissioning. To oversee Dornan’s expansion and future growth plans, Padraig Finn has been appointed as Operations Director of Dornan’s European Pharmaceutical wing, charged with leading Dornan’s ambitious European pharmaceutical operations.
An instrumentation and control systems engineer, Padraig Finn joins Dornan from Jacobs, where he held the role of Vice President of Business Development in Europe. Padraig has significant experience working with various sectors across Europe, which he says opened his eyes to opportunities for Ireland head-quartered Dornan Group to sell their services overseas with pharmaceutical clients.
Padraig Finn said that having been one of the first Irish construction companies to expand into Europe almost 15 years ago, Dornan is now looking again to grow and expand its pharmaceutical client base in Europe. It recently won another large project in Belgium with a global biopharma company, focusing on neurology and immunology.
“We are looking for ambitious and experienced professionals to join our team and play a critical role in this journey,” he said. “We anticipate an over €5bn investment from the sector within Europe over the next five years in pharmaceutical projects including biotech, fill-finish, API, gene and cell therapy as well as blood fractionation and vaccines. Our team has the unique skillsets to meet these needs, developed over the last 50-plus years working closely with multinationals that have entered the pharmaceutical sector in Ireland, delivering specialist engineering and construction solutions.
Dornan is recognised internationally as a leading, fully integrated engineering services contractor.
“Our track record for responsibility – from early engagement through integrated project delivery, engineered off-site solutions and modularisation, a strong safety and quality culture in everything we do, to delivering on client expectations – continues to win us repeat business with major pharmaceutical clients,” Padraig Finn added.
“We also have a reputation as a progressive construction company, continually investing in the latest technology, software and hardware, and in training programmes to ensure our people work comfortably and effectively with these technologies. This means our clients always get state-of-the-art engineered solutions and innovative technology such as virtual and augmented reality that enables our clients to assess immersive solutions where physical and virtual objects are integrated at different levels.
“We look forward to welcoming new team members who share our vision for the future.”
Today, Dornan Group directly employs greater than 1,300 people across its various offices and projects in Ireland, UK, and Europe, and it employs a further 2,500 through its supply chain. This expansion reflects the success and continued growth of the company in Ireland, the UK and Europe.
Visit dornan.ie for more information on Dornan’s current opportunities across Europe.